Added to YB: 2026-10-05
Pitch date: 2026-10-01
NRXS [bullish]
NeurAxis, Inc.
+6.61%
current return
Author Info
Microcap Opportunities is a community dedicated to finding the best opportunities in the MicroCap space for US and Canadian listings primarily. Sign up for the newsletter.
Company Info
NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States.
Market Cap
$85.1M
Pitch Price
$7.26
Price Target
N/A
Dividend
N/A
EV/EBITDA
-10.27
P/E
-8.74
EV/Sales
14.50
Sector
Health Care Equipment and Supplies
Category
growth
Multibaggers, Turnarounds and Steady Eddies — September 2026 - NeurAxis, Inc.
NRXS (hold): NeurAxis closed September at $7.43, up 133.6% from its $3.18 entry. Cigna added 16.7 million commercially covered lives for IB-Stim, taking total coverage near 120 million, or about two-thirds of the market. Further payer coverage and sales-force expansion are expected to accelerate hospital and VA revenue; Cigna is not one of the two 20-million-plus-life carriers previously discussed, and the next quarterly report should provide more detail for modeling growth.
Read full article (2 min)